A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a ...

A world-first human trial of a drug designed to treat the underlying cause of type 1 diabetes has begun in Australia.

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...